FR2876903B1 - Utilisation d'un principe actif pour lutter contre l'alopecie, et compositions associees - Google Patents

Utilisation d'un principe actif pour lutter contre l'alopecie, et compositions associees

Info

Publication number
FR2876903B1
FR2876903B1 FR0452429A FR0452429A FR2876903B1 FR 2876903 B1 FR2876903 B1 FR 2876903B1 FR 0452429 A FR0452429 A FR 0452429A FR 0452429 A FR0452429 A FR 0452429A FR 2876903 B1 FR2876903 B1 FR 2876903B1
Authority
FR
France
Prior art keywords
alopecia
active ingredient
associated compositions
compositions
ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0452429A
Other languages
English (en)
Other versions
FR2876903A1 (fr
Inventor
Jean Paufique
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe Industrielle Limousine dApplication Biologique SA SILAB
Original Assignee
Societe Industrielle Limousine dApplication Biologique SA SILAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe Industrielle Limousine dApplication Biologique SA SILAB filed Critical Societe Industrielle Limousine dApplication Biologique SA SILAB
Priority to FR0452429A priority Critical patent/FR2876903B1/fr
Publication of FR2876903A1 publication Critical patent/FR2876903A1/fr
Application granted granted Critical
Publication of FR2876903B1 publication Critical patent/FR2876903B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
FR0452429A 2004-10-25 2004-10-25 Utilisation d'un principe actif pour lutter contre l'alopecie, et compositions associees Expired - Lifetime FR2876903B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0452429A FR2876903B1 (fr) 2004-10-25 2004-10-25 Utilisation d'un principe actif pour lutter contre l'alopecie, et compositions associees

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0452429A FR2876903B1 (fr) 2004-10-25 2004-10-25 Utilisation d'un principe actif pour lutter contre l'alopecie, et compositions associees

Publications (2)

Publication Number Publication Date
FR2876903A1 FR2876903A1 (fr) 2006-04-28
FR2876903B1 true FR2876903B1 (fr) 2007-08-03

Family

ID=34951050

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0452429A Expired - Lifetime FR2876903B1 (fr) 2004-10-25 2004-10-25 Utilisation d'un principe actif pour lutter contre l'alopecie, et compositions associees

Country Status (1)

Country Link
FR (1) FR2876903B1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3004346A1 (fr) * 2013-04-10 2014-10-17 Caster Composition pour les chutes de cheveux localisees
CN110123659B (zh) * 2019-05-29 2022-08-30 名臣健康用品股份有限公司 一种防脱发组合物及其在制备防脱发洗护产品中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU86021A1 (fr) * 1985-07-24 1987-02-04 Oreal Utilisation de pourdre de graines de lupin dans la realisation de compositions cosmetiques ou dermopharmaceutiques,et compositions ainsi obtenues
GB9718520D0 (en) * 1997-09-01 1997-11-05 Dalgety Plc Functional protein concentrates and isolates
FR2778565B1 (fr) * 1998-05-14 2000-07-28 Silab Sa Procede d'extraction de principes actifs vegetaux a partir de graines de lupin blanc doux, extrait obtenu et composition utilisant au moins une fraction de cet extrait
FR2797184B1 (fr) * 1999-08-02 2003-07-04 Silab Sa Procede d'obtention d'un principe actif anti-chute des cheveux, principe actif obtenu, composition et procede de lutte contre la chute des cheveux

Also Published As

Publication number Publication date
FR2876903A1 (fr) 2006-04-28

Similar Documents

Publication Publication Date Title
CY2016042I1 (el) Νεες ετεροκυκλικες ενωσεις δραστικες ως αναστολεις των βητα-λακταμασων
IL182527A0 (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
FR12C0019I1 (fr) O-cyclopropyle-carboxanilides et leur utilisation comme fongicides
ZA200705750B (en) Compositions and methods for stabilizing active pharmaceutical ingredients
MX2007014892A (es) Formas polimorficas del ester etilico del acido 3-[(2-{[4-(hexiloxicarbonilamino-imino-metil)-fenilamino]-metil}- 1-metil-h-bencimidazol-5-carbonil)-piridin-2-il--amino]propionico .
RS52169B (en) STABLE LAKVINIMOD PREPARATIONS
FR2891459B1 (fr) Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
IS8216A (is) 4-(metýl súlfónýl amínó) fenýl hliðstæður sem vaníllóíð mótlyf, og sem sýna frábæra kvalastillandi virkni, og lyfjafræðilegar samsetningar, sem innihalda þær
MA28512B1 (fr) Derive heterocyclique accole, composition medicamenteuse en contenant, et son utilisation medicamenteuse
IL217713A0 (en) Compounds and compositions for delivering active agents
FR2873585B1 (fr) Nouvelles formulations galeniques de principes actifs
IL229510A0 (en) A dosage form containing pantoprazole as an active ingredient
HK1105202A1 (en) Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient
IL181056A (en) The pyrimidine compounds are preserved in position 5 and positions 4,2 in reliable phenyl and pharmaceutical preparations containing them
FR2908045B1 (fr) Utilisation anti-pelliculaire d'un principe actif riche en tannis hydrolysables
MA29030B1 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
EP1745004A4 (fr) Composes d'aryle cetone et compositions pour la delivrance d'agents actifs
ITFI20050041A1 (it) Idrossammati come inibitori dell'istone deacelitasi, loro preparazione e formulazioni farmaceutiche che li contengono
IS8128A (is) Samsetningar sem fela í sér paroxetín og 2-(S)-(4-flúor-2-metýl-fenýl)-píperasín-1-karboxýlsýru[1-(R)-(3,5-bis-tríflúor-2-metýl-fenýl)-etýl]-metýl-amíð til að meðhöndla þunglyndi og/eða kvíða
FR2887447B1 (fr) Utilisation d'un peptide comme principe actif amincissant
EP1791423A4 (fr) Compositions et procedes permettant de traiter des problemes dermatologiques se caracterisant par une hyperproliferation
FR2876903B1 (fr) Utilisation d'un principe actif pour lutter contre l'alopecie, et compositions associees
FR2890312B1 (fr) Procede d'obtention d'un principe actif repulpant, principe actif obtenu et compositions cosmetiques l'incluant
CR8955A (es) Hexadecasacaridos biotinilados, su preparacion y su utilizacion
ITMI20040313A1 (it) Formulazioni gastroprotette di inbitori di enzimi ad attivita' alfa-amilasica

Legal Events

Date Code Title Description
CJ Change in legal form
PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20